FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386583501> ?p ?o ?g. }

• W4386583501 endingPage "107424" @default.
• W4386583501 startingPage "107424" @default.
• W4386583501 abstract "Clear cell renal cell carcinoma (ccRCC) is a prevalent kidney malignancy with a pressing need for innovative therapeutic strategies. In this context, emerging research has focused on exploring the medicinal potential of plants such as Rhazya stricta. Nevertheless, the complex molecular mechanisms underlying its potential therapeutic efficacy remain largely elusive. Our study employed an integrative approach comprising data mining,network pharmacology,tissue cell type analysis, and molecular modelling approaches to identify potent phytochemicals from R. stricta, with potential relevance for ccRCC treatments. Initially, we collected data on R. stricta's phytochemical from public databases. Subsequently, we integrated this information with differentially expressed genes (DEGs) in ccRCC, which were derived from microarray datasets(GSE16441,GSE66270, and GSE76351). We identified potential intersections between R. stricta and ccRCC targets, which enabled us to construct a compound-genes-pathway network using Cytoscape software. This helped illuminate R. stricta's multi-target pharmacological effects on ccRCC. Moreover, tissue cell type analysis added another layer of insight into the cellular specificity of potential therapeutic targets in the kidney. Through further Kaplan-Meier survival analysis, we pinpointed MMP9,ACE,ERBB2, and HSP90AA1 as prospective diagnostic and prognostic biomarkers for ccRCC. Notably, our study underscores the potential of R. stricta derived compounds-namely quebrachamine,corynan-17-ol, stemmadenine,strictanol,rhazinilam, and rhazimolare-to impede ccRCC progression by modulating the activity of MMP9,ACE,ERBB2, and HSP90AA1 genes. Further, molecular docking and dynamic simulations confirmed the plausible binding affinities of these compounds. Despite these promising findings, we recognize the need for comprehensive in vivo and in vitro studies to further investigate the pharmacokinetics and biosafety profiles of these compounds." @default.
• W4386583501 created "2023-09-11" @default.
• W4386583501 creator A5003263944 @default.
• W4386583501 creator A5020896193 @default.
• W4386583501 creator A5033890490 @default.
• W4386583501 creator A5034811978 @default.
• W4386583501 creator A5054743424 @default.
• W4386583501 creator A5058191381 @default.
• W4386583501 creator A5060605576 @default.
• W4386583501 creator A5068225695 @default.
• W4386583501 date "2023-10-01" @default.
• W4386583501 modified "2023-10-17" @default.
• W4386583501 title "Unveiling the multi-target compounds of Rhazya stricta: Discovery and inhibition of novel target genes for the treatment of clear cell renal cell carcinoma" @default.
• W4386583501 cites W1943317391 @default.
• W4386583501 cites W1986553481 @default.
• W4386583501 cites W1994581907 @default.
• W4386583501 cites W2001195644 @default.
• W4386583501 cites W200461197 @default.
• W4386583501 cites W2006800189 @default.
• W4386583501 cites W2012980021 @default.
• W4386583501 cites W2083925247 @default.
• W4386583501 cites W2099908487 @default.
• W4386583501 cites W2106391842 @default.
• W4386583501 cites W2120176865 @default.
• W4386583501 cites W2122683221 @default.
• W4386583501 cites W2132629607 @default.
• W4386583501 cites W2133641393 @default.
• W4386583501 cites W2159675211 @default.
• W4386583501 cites W2168938595 @default.
• W4386583501 cites W2246620632 @default.
• W4386583501 cites W2413513935 @default.
• W4386583501 cites W2422684078 @default.
• W4386583501 cites W2588200711 @default.
• W4386583501 cites W2593436234 @default.
• W4386583501 cites W2739999456 @default.
• W4386583501 cites W2747275153 @default.
• W4386583501 cites W2801088198 @default.
• W4386583501 cites W2810166643 @default.
• W4386583501 cites W2810409999 @default.
• W4386583501 cites W2883869155 @default.
• W4386583501 cites W2946657092 @default.
• W4386583501 cites W2949305189 @default.
• W4386583501 cites W2973451075 @default.
• W4386583501 cites W2985542241 @default.
• W4386583501 cites W2997274725 @default.
• W4386583501 cites W3038811719 @default.
• W4386583501 cites W3112662083 @default.
• W4386583501 cites W3133530971 @default.
• W4386583501 cites W3154258817 @default.
• W4386583501 cites W3162893150 @default.
• W4386583501 cites W3175773220 @default.
• W4386583501 cites W3195445986 @default.
• W4386583501 cites W3211909891 @default.
• W4386583501 cites W4220953887 @default.
• W4386583501 cites W4225373799 @default.
• W4386583501 cites W4255677297 @default.
• W4386583501 cites W4281632330 @default.
• W4386583501 cites W4309079637 @default.
• W4386583501 cites W4310817585 @default.
• W4386583501 cites W4322388214 @default.
• W4386583501 cites W4362731391 @default.
• W4386583501 doi "https://doi.org/10.1016/j.compbiomed.2023.107424" @default.
• W4386583501 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37717527" @default.
• W4386583501 hasPublicationYear "2023" @default.
• W4386583501 type Work @default.
• W4386583501 citedByCount "0" @default.
• W4386583501 crossrefType "journal-article" @default.
• W4386583501 hasAuthorship W4386583501A5003263944 @default.
• W4386583501 hasAuthorship W4386583501A5020896193 @default.
• W4386583501 hasAuthorship W4386583501A5033890490 @default.
• W4386583501 hasAuthorship W4386583501A5034811978 @default.
• W4386583501 hasAuthorship W4386583501A5054743424 @default.
• W4386583501 hasAuthorship W4386583501A5058191381 @default.
• W4386583501 hasAuthorship W4386583501A5060605576 @default.
• W4386583501 hasAuthorship W4386583501A5068225695 @default.
• W4386583501 hasConcept C104317684 @default.
• W4386583501 hasConcept C143998085 @default.
• W4386583501 hasConcept C150194340 @default.
• W4386583501 hasConcept C151730666 @default.
• W4386583501 hasConcept C2777472916 @default.
• W4386583501 hasConcept C2779343474 @default.
• W4386583501 hasConcept C2781278892 @default.
• W4386583501 hasConcept C54355233 @default.
• W4386583501 hasConcept C70721500 @default.
• W4386583501 hasConcept C71924100 @default.
• W4386583501 hasConcept C8415881 @default.
• W4386583501 hasConcept C86803240 @default.
• W4386583501 hasConceptScore W4386583501C104317684 @default.
• W4386583501 hasConceptScore W4386583501C143998085 @default.
• W4386583501 hasConceptScore W4386583501C150194340 @default.
• W4386583501 hasConceptScore W4386583501C151730666 @default.
• W4386583501 hasConceptScore W4386583501C2777472916 @default.
• W4386583501 hasConceptScore W4386583501C2779343474 @default.
• W4386583501 hasConceptScore W4386583501C2781278892 @default.
• W4386583501 hasConceptScore W4386583501C54355233 @default.
• W4386583501 hasConceptScore W4386583501C70721500 @default.
• W4386583501 hasConceptScore W4386583501C71924100 @default.
• W4386583501 hasConceptScore W4386583501C8415881 @default.

• next